The B cell receptor (BCR) activates numerous survival and proliferation pathways, and can signal in an antigen-dependent or antigen-independent (tonic) fashion. Here, Young and Staudt discuss the signalling cascades involved, examine recent evidence for a role of BCR signalling in different subtypes of B cell lymphomas and provide an overview of pipeline candidates that target components of the BCR signalling cascade.
- Ryan M. Young
- Louis M. Staudt